Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan

Background and Objectives: Fenofibrate, a PPAR-α agonist, has been demonstrated to reduce the progression of diabetic retinopathy (DR) and the need for laser treatment in a FIELD (Fenofibrate Intervention and Event Lowering in Diabetes) study. However, in the subgroup of patients without pre-existin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying-Chieh, Chen, Yu-Ching, Horng, Jorng-Tzong, Chen, Jui-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466234/
https://www.ncbi.nlm.nih.gov/pubmed/32751875
http://dx.doi.org/10.3390/medicina56080385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466234/
https://www.ncbi.nlm.nih.gov/pubmed/32751875
http://dx.doi.org/10.3390/medicina56080385

Ejemplares similares